Abstract

L-type Ca2+ (CaV1) channels transduce channel activities into nuclear signals critical to neuritogenesis. Also, standalone peptides encoded by CaV1 DCT (distal carboxyl-terminus) act as nuclear transcription factors reportedly promoting neuritogenesis. Here, by focusing on exemplary CaV1.3 and cortical neurons under basal conditions, we discover that cytosolic DCT peptides downregulate neurite outgrowth by the interactions with CaV1’s apo-calmodulin binding motif. Distinct from nuclear DCT, various cytosolic peptides exert a gradient of inhibitory effects on Ca2+ influx via CaV1 channels and neurite extension and arborization, and also the intermediate events including CREB activation and c-Fos expression. The inhibition efficacies of DCT are quantitatively correlated with its binding affinities. Meanwhile, cytosolic inhibition tends to facilitate neuritogenesis indirectly by favoring Ca2+-sensitive nuclear retention of DCT. In summary, DCT peptides as a class of CaV1 inhibitors specifically regulate the channel activity-neuritogenesis coupling in a variant-, affinity-, and localization-dependent manner.

When present in the cytosol, a variety of peptides encoded by the distal carboxyl-termini of the L-type CaV1 calcium channels downregulate channel activity and neurite outgrowth.

Details

Title
Cytosolic peptides encoding CaV1 C-termini downregulate the calcium channel activity-neuritogenesis coupling
Author
Yang, Yaxiong 1   VIAFID ORCID Logo  ; Yu, Zhen 1 ; Geng Jinli 1 ; Liu, Min 2 ; Liu, Nan 3 ; Li, Ping 4 ; Hong, Weili 4   VIAFID ORCID Logo  ; Yue Shuhua 4   VIAFID ORCID Logo  ; He, Jiang 2 ; Ge Haiyan 2 ; Qian, Feng 5 ; Xiong, Wei 6 ; Wang, Ping 7 ; Sen, Song 2 ; Li, Xiaomei 2   VIAFID ORCID Logo  ; Fan Yubo 4   VIAFID ORCID Logo  ; Liu, Xiaodong 1   VIAFID ORCID Logo 

 Beihang University, Key Laboratory for Biomechanics and Mechanobiology of Ministry of Education, Beijing Advanced Innovation Center for Biomedical Engineering, School of Biological Science and Medical Engineering, School of Engineering Medicine, Beijing, China (GRID:grid.64939.31) (ISNI:0000 0000 9999 1211); Beihang University, X-Laboratory for Ion-Channel Engineering, Beijing, China (GRID:grid.64939.31) (ISNI:0000 0000 9999 1211) 
 Tsinghua University, School of Medicine, Beijing, China (GRID:grid.12527.33) (ISNI:0000 0001 0662 3178) 
 Yunnan University, Center for Life Sciences, School of Life Sciences, Kunming, China (GRID:grid.440773.3) (ISNI:0000 0000 9342 2456) 
 Beihang University, Key Laboratory for Biomechanics and Mechanobiology of Ministry of Education, Beijing Advanced Innovation Center for Biomedical Engineering, School of Biological Science and Medical Engineering, School of Engineering Medicine, Beijing, China (GRID:grid.64939.31) (ISNI:0000 0000 9999 1211) 
 Tsinghua University, School of Pharmaceutical Sciences, Beijing, China (GRID:grid.12527.33) (ISNI:0000 0001 0662 3178) 
 Tsinghua University, School of Life Sciences, Beijing, China (GRID:grid.12527.33) (ISNI:0000 0001 0662 3178) 
 Zhejiang University, Laboratory for Biomedical Engineering of Ministry of Education, Hangzhou, China (GRID:grid.13402.34) (ISNI:0000 0004 1759 700X) 
Publication year
2022
Publication date
2022
Publisher
Nature Publishing Group
e-ISSN
23993642
Source type
Scholarly Journal
Language of publication
English
ProQuest document ID
2666718653
Copyright
© The Author(s) 2022. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.